$38.33
-0.93-2.37%
Ult. Agg.: Nov 17, 12:36 PM

The average analyst price target for Xenon Pharmaceuticals is $61.89, 61.5% above the current price. Of 18 analysts, 17 rate it Buy and 1 Hold. Targets range from $46 to $90. The latest change came on Oct 6, 2026, when Guggenheim assumed coverage of Xenon Pharmaceuticals with a Buy rating and a $73 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months